Abstract:BACKGROUND: Initially identified for their capability to induce heterotopic bone formation, bone morphogenetic proteins (BMPs) are multifunctional growth factors that belong to the transforming growth factor beta superfamily. Using cellular and molecular genetic approaches, recent studies have implicated intra-ovarian BMPs as potent regulators of ovarian follicular function. The bi-directional communication of oocytes and the surrounding somatic cells is mandatory for normal follicle development and oocyte maturation. This review summarizes the current knowledge on the physiological role and molecular determinants of these ovarian regulatory factors within the human germline-somatic regulatory loop. OBJECTIVE AND RATIONALE: The regulation of ovarian function remains poorly characterized in humans because, while the fundamental process of follicular development and oocyte maturation is highly similar across species, most information on the regulation of ovarian function is obtained from studies using rodent models. Thus, this review focuses on the studies that used human biological materials to gain knowledge about human ovarian biology and disorders and to develop strategies for preventing, diagnosing and treating these abnormalities. SEARCH METHODS: Relevant English-language publications describing the roles of BMPs or growth differentiation factors (GDFs) in human ovarian biology and phenotypes were comprehensively searched using PubMed and the Google Scholar database. The publications included those published since the initial identification of BMPs in the mammalian ovary in 1999 through July 2016. OUTCOMES: Studies using human biological materials have revealed the expression of BMPs, GDFs and their putative receptors as well as their molecular signaling in the fundamental cells (oocyte, cumulus/granulosa cells (GCs) and theca/stroma cells) of the ovarian follicles throughout follicle development. With the availability of recombinant human BMPs/GDFs and the development of immortalized human cell lines, functional studies have demonstrated the physiological role of intra-ovarian BMPs/GDFs in all aspects of ovarian functions, from follicle development to steroidogenesis, cell-cell communication, oocyte maturation, ovulation and luteal function. Furthermore, there is crosstalk between these potent ovarian regulators and the endocrine signaling system. Dysregulation or naturally occurring mutations within the BMP system may lead to several female reproductive diseases. The latest development of recombinant BMPs, synthetic BMP inhibitors, gene therapy and tools for BMP-ligand sequestration has made the BMP pathway a potential therapeutic target in certain human fertility disorders; however, further clinical trials are needed. Recent studies have indicated that GDF8 is an intra-ovarian factor that may play a novel role in regulating ovarian functions in the human ovary. WIDER IMPLICATIONS: Intra-ovarian BMPs/GDFs are critical regulators of folliculogenesis and human ovarian functions. Any dysregulation or variations in these ligands or their receptors may affect the related intracellular signaling and influence ovarian functions, which accounts for several reproductive pathologies and infertility. Understanding the normal and pathological roles of intra-ovarian BMPs/GDFs, especially as related to GC functions and follicular fluid levels, will inform innovative approaches to fertility regulation and improve the diagnosis and treatment of ovarian disorders.

The function of bone morphogenetic proteins in the human ovary

BMP2 increases the production of BDNF through the upregulation of proBDNF and furin expression in human granulosa-lutein cells

Roles of Bone Morphogenetic Proteins and Their Receptors in Mammalian Reproduction

Oocyte-somatic cell interactions in the human ovary-novel role of bone morphogenetic proteins and growth differentiation factors.

High Bone Morphogenetic Protein-15 Level in Follicular Fluid is Associated with High Quality Oocyte and Subsequent Embryonic Development

Connective Tissue Growth Factor Mediates Bone Morphogenetic Protein 2-Induced Increase in Hyaluronan Production in Luteinized Human Granulosa Cells

[Women with Poor Response to Ovarian Stimulation Have Increased Follicular Bone Morphogenetic Protein-15 Levels].

Regulation of Follicular Development and Differentiation by Intra-Ovarian Factors and Endocrine Hormones.

Stage-specific Expression of Bone Morphogenetic Protein Type I and Type II Receptor Genes: Effects of Follicle-Stimulating Hormone on Ovine Antral Follicles

Expression of Bone Morphogenetic Protein Receptor (BMPR) During Perinatal Ovary Development and Primordial Follicle Formation in the Hamster: Possible Regulation by FSH

Hormonal Regulation of Bone Morphogenetic Protein Receptor (bmpr) Expression in Perinatal Hamster Ovary, and the Effect of Bmps on the Formation and Development of Primordial Follicles.

Bone Morphogenetic Protein 2 Regulates Cell-Cell Communication by Down-Regulating Connexin43 Expression in Luteinized Human Granulosa Cells

Gonadotrophin-induced Paracrine Regulation of Human Oocyte Maturation by BDNF and GDNF Secreted by Granulosa Cells.

Basic Fibroblast Growth Factor Promotes Prehierarchical Follicle Growth and Yolk Deposition in the Chicken.

Characteristic of factors influencing the proper course of folliculogenesis in mammals

Expression of bone morphogenetic protein-15 in human oocyte and cumulus granulosa cells primed with recombinant follicle-stimulating hormone followed by human chorionic gonadotropin.

Reciprocal Stimulating Effects of Bfgf and FSH on Chicken Primordial Follicle Activation Through AKT and ERK Pathway.

Bone morphogenetic protein 2- and estradiol-17β-induced changes in ovarian transcriptome during primordial follicle formation†

Gonadotropins Regulate Ovarian Germ Cell Mitosis/meiosis Decision in the Embryonic Chicken

Studying the Functions of TGF-β Signaling in the Ovary.

Evidence for an inhibitory role of bone morphogenetic protein(s) in the follicular-luteal transition in cattle